System may be flawed but nonetheless Missling trial designs have failed. I remember when people on this board hailed him a genius for being so frugal and only enrolling minimal patients needed to pass the trial. Turns out he should have spent that money on a better CRO and more patients so we could have passed the first time. Now we need additional ReTT trials if they even continue with that program. Alz is a still a toss up, hence why we are at a 9 year low in sp. missling has proven himself incompetent every step of the way. But hey he padded the coffers with several more years of runway so he can continue to kick the can and get paid until he’s ready to retire!
seem to be better than what’s been approved in EVERY aspect. ADVANTAGE to those who complete the test including the Placebo group. You get to continue with the REAL DRUG. Which in time the OLE should show a whole lot better for ALL who continued to test the Drug. We all know we have no "Safety Issues" with 2-73 One thing came to light in one of the trials. Give the drug at time the patient goes to bed for the nite and zero bad side effects. One of these days we will get comments and results of those tests.
News 
Market Data 
Discover 
AI
